The iPeer2Peer Program for Adolescents With Juvenile Idiopathic Arthritis
NCT ID: NCT03116763
Last Updated: 2023-11-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
164 participants
INTERVENTIONAL
2017-03-28
2023-04-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
iPeer2Peer Mentorship
In addition to standard care, youth in the experimental group will receive the iPeer2Peer program, a peer mentorship program that will provide modeling and reinforcement of self-management by pre-screened and trained peer mentors (young adults with JIA aged 18-22 years who have learned to function successfully with their disease). Mentors will encourage participants to develop and engage in self-management skills and provide social support.
iPeer2Peer Mentorship
10 sessions of 20-30 minute Skype calls conducted over 5-12 weeks.
Control Group
The control group will receive standard care but without the iPeer2Peer program.
Active Comparator: Control Group
The control group will receive standard care but without the iPeer2Peer program.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
iPeer2Peer Mentorship
10 sessions of 20-30 minute Skype calls conducted over 5-12 weeks.
Active Comparator: Control Group
The control group will receive standard care but without the iPeer2Peer program.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* rheumatologist-diagnosed JIA according to ILAR criteria
* able to speak and read English
* access to a computer, smartphone or tablet capable of using free Skype software (note: participants who do not have adequate Internet access will be provided with portable Internet sticks)
* willing and able to complete online measures.
Exclusion Criteria
* major co-morbid illnesses (medical or psychiatric conditions) likely to influence HRQL assessment
* participating in other peer support or self-management interventions.
12 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Provincial Health Services Authority
OTHER
IWK Health Centre
OTHER
Children's Hospital of Eastern Ontario
OTHER
The Hospital for Sick Children
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jennifer Stinson
Senior Scientist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jennifer N Stinson, CPNP, PhD
Role: PRINCIPAL_INVESTIGATOR
The Hospital for Sick Children
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alberta Children's Hospital
Calgary, Alberta, Canada
BC Children's Hospital
Vancouver, British Columbia, Canada
The IWK Health Centre
Halifax, Nova Scotia, Canada
Children's Hospital - London Health Sciences
London, Ontario, Canada
Children's Hospital of Eastern Ontario (CHEO)
Ottawa, Ontario, Canada
The Hospital for Sick Children
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Nishat F, Kelenc L, Berard R, Duffy C, Feldman B, Forgeron P, Huber AM, Luca N, Schmeling H, Spiegel L, Tucker L, Watanabe-Duffy K, Killackey T, Lalloo C, Wiles B, Nair A, Olaizola S, McDermott B, Tavangar F, Kohut SA, Stinson JN. Assessing the impact of the iPeer2Peer program for adolescents with juvenile idiopathic arthritis: a mixed-methods randomized controlled trial. Pediatr Rheumatol Online J. 2024 Dec 27;22(1):109. doi: 10.1186/s12969-024-01052-5.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1000054878
Identifier Type: -
Identifier Source: org_study_id